title: Bone metastases from poorly differentiated adenocarcinoma of the prostate diagnosed by In-111 ProstaScint (Capromab Pendetide) images with negative results of Tc-99m MDP bone scan and without significant elevation of prostate-specific antigen.
authors.affiliation: Department of Radiology, Emory University Hospital, Atlanta, Georgia 30322, USA.
authors.forename: S
authors.initials: S
authors.lastname: Norris
authors.forename: R
authors.initials: R
authors.lastname: Halkar
authors.forename: J
authors.initials: J
authors.lastname: Galt
authors.forename: J
authors.initials: J
authors.lastname: Petros
authors.forename: J
authors.initials: J
authors.lastname: Keller
mesh_terms: D000230:Adenocarcinoma / Q000000981:diagnostic imaging* / Q000556:secondary*; D000911:Antibodies, Monoclonal; D001859:Bone Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary*; D006801:Humans; D007205:Indium Radioisotopes; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000473:pathology; D019275:Radiopharmaceuticals; D013669:Technetium Tc 99m Medronate; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D000911:Antibodies, Monoclonal; D007205:Indium Radioisotopes; D019275:Radiopharmaceuticals; C101315:Capromab Pendetide; D017430:Prostate-Specific Antigen; D013669:Technetium Tc 99m Medronate